Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Counterfeit drug trade in Russia costs pharma industry > $US250m/year

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Counterfeit drug trade in Russia costs pharma industry > $US250m/year. Pharmacoecon. Outcomes News 363, 11 (2002). https://doi.org/10.1007/BF03279092

    Download citation

    Keywords

    • Fold Increase
    • Health Economic
    • Intellectual Property
    • Outcome News
    • Pharmaceutical Company